Chums, does anybody know from experience what a Fat Prophets recommendation does to a share price? SAR's writeup in today' Herald was from a FP analyst. The market depth looks amazingly good for a run, but I'm a bit wary of buying into it.
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution
